Evidence map›Paper›PMID 12215907›Full record

ReviewGenes and immunity2002

The genetics of systemic lupus erythematosus: putting the pieces together.

J A Kelly, K L Moser, J B Harley

Abstract readReview
PubMed Publisher
In one paragraph

Review in Genes and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Autoantibodies in systemic lupus erythematosus.Pediatric nephrology (Berlin, Germany) · 2012
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Current status of lupus genetics.Arthritis research & therapy · 2007
    Review
  20. Unraveling the genetics of systemic lupus erythematosus.Springer seminars in immunopathology · 2006
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J A KellyArthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. jennifer-kelly@omrf.ouhsc.edu
K L Moser
J B Harley

Funding

X-LINKED EXTENSION OF THE REVISED HASEMAN-ELSTON ALGORITHM FOR LINKAGE ANALYSISP41RR003655 · NCRR · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI ELSTON, ROBERT C. · 1987 to 2011
$11.5M
HLA GENE COMPLEMENTATION IN PRIMARY SJOGREN'S AND LUPUSR01AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KOTTYAN, LEAH CLAIRE, WEIRAUCH, MATTHEW TYSON · 1987 to 2025
$7.8M
GENETIC ASSOCIATION WITH LUPUS IN AMERICAN BLACKSR01AR042460 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 1993 to 2009
$5.1M
Genetic Linkage in LupusR37AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2005 to 2014
$4.2M
SPECIALIZED CENTER OF RESEARCH IN SLEP50AR045231 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P · 1998 to 2001
$2.2M
Robust Linkage Methods for Human Pedigree DataR01HG001577 · NHGRI · CASE WESTERN RESERVE UNIVERSITY · PI GODDARD, KATRINA A · 2001 to 2004
$758k
ROBUST LINKAGE METHODS FOR HUMAN PEDIGREE DATAR29HG001577 · NHGRI · CASE WESTERN RESERVE UNIVERSITY · PI OLSON, JANE M. · 1996 to 2000
$101k
IG REPERTOIRE OF COMBINATORIAL AUTOANTIBODIES IN PBCR29AI031585 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI LEUNG, PATRICK S · 1993 to 1997
–
NCRR NIH HHS RR03655NHGRI NIH HHS HG01577NIAID NIH HHS AI24717NIAID NIH HHS AI31585NIAMS NIH HHS AR42460NIAMS NIH HHS AR45231
6 · The paper itself

Abstract

With lambda(s) estimates of 10 to 20 and other evidence of familial aggregation, as well as a monozygotic twin concordance rate >20, systemic lupus erythematosus (SLE) would appear to be a very promising phenotype using modern genetic approaches. Indeed, genetic associations are already known at numerous candidate loci including various HLA alleles, complement component genes, Fcgamma receptors, and others, and murine genetic studies of lupus models have provided additional candidate genes and potential syntenic linkages to evaluate in man. The completed genetic linkage studies performed on various collections of pedigrees multiplex for SLE have identified 60 susceptibility loci with varying degrees of evidence for linkage in man. Seven of these meet or exceed the threshold for significant linkage (LOD > or = 3.3 or P < or = 0.00005) at 1q22-23, 1q41, 2q37, 4p16, 6p21-11, 16q13 and 17p13. In addition, these linkages usually dominate in one ethnicity or another, suggesting that the responsible polymorphisms, once identified, will also vary by ethnicity. Evidence that these linkages can be reproduced range from outright independent confirmation (1q41, 4p16 and 6p21) to additional suggestive evidence in the genomic region of the purported linkage (1q22-23 and 2q37). The results now available suggest that human lupus genetics are robust and that gene identification should be possible using existing genetic approaches and technologies.

Indexed as

AnimalsChromosome MappingComplement System ProteinsDisease Models, AnimalGenetic LinkageGenetic Predisposition to DiseaseHLA AntigensHumansLupus Erythematosus, SystemicMiceMice, Inbred C57BLMice, Inbred MRL lprMice, Inbred NZBReceptors, IgGComplement System ProteinsHLA AntigensReceptors, IgG

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.